FDA Approves Expanded Use Of GSK's Ovarian Cancer Drug Zejula

The FDA has approved GlaxoSmithKline plc's (GSK) ovarian cancer drug ZEJULA for an additional indication.

from RTT - Biotech https://ift.tt/2N60ALf
via IFTTT